Vanguard Fiduciary Trust »

Mink Therapeutics shares owned by Vanguard Fiduciary Trust

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Vanguard Fiduciary Trust from 13F filings

Historical chart of Vanguard Fiduciary Trust investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Vanguard Fiduciary Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Vanguard Fiduciary Trust

Quarter filed Position value Share count Share price at filing
2026-03-31 $87k 8.3k 10.53

More positions owned by Vanguard Fiduciary Trust

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Wal-Mart Stores (WMT)

View all positions for Vanguard Fiduciary Trust

Top funds holding Mink Therapeutics

Vanguard Group
Vanguard Capital Management
Geode Capital Management
Longbow Finance SA
UBS Group
Renaissance Technologies
Vanguard Fiduciary Trust
BlackRock
Steward Partners Investment Advisory
Tower Research Capital
Annis Gardner Whiting Capital Advisors
Covestor
Advisor Group Holdings
Morgan Stanley
Citigroup

View all funds holding Mink Therapeutics